LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,001,812 | -45.1% | 672,357 | -16.0% | 0.28% | -55.8% |
| Q2 2023 | $1,825,541 | +44.0% | 800,676 | +23.2% | 0.64% | +52.6% |
| Q1 2023 | $1,267,500 | +18.9% | 650,000 | 0.0% | 0.42% | 0.0% |
| Q4 2022 | $1,066,000 | -2.6% | 650,000 | +18.2% | 0.42% | +36.6% |
| Q3 2022 | $1,095,000 | +12.7% | 550,000 | +22.2% | 0.31% | -25.4% |
| Q2 2022 | $972,000 | -19.4% | 450,000 | +38.5% | 0.41% | +112.4% |
| Q1 2022 | $1,206,000 | +170.4% | 325,000 | +348.9% | 0.19% | +19.1% |
| Q4 2021 | $446,000 | – | 72,406 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHF (GPE), LLC | 937,500 | $1,397 | 25.49% |
| Vida Ventures Advisors, LLC | 2,282,084 | $3,400,305 | 5.26% |
| Perceptive Advisors | 57,558,451 | $85,762,091 | 2.86% |
| 22NW, LP | 2,211,678 | $3,295,400 | 2.35% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $4,922,324 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $2,682,000 | 0.38% |
| Affinity Asset Advisors, LLC | 672,357 | $1,001,812 | 0.28% |
| MYDA Advisors LLC | 200,000 | $298,000 | 0.10% |
| Logos Global Management LP | 280,000 | $417,200 | 0.06% |
| Old Well Partners, LLC | 32,200 | $47,978 | 0.04% |